Home › PAREXEL Expands Model-Based Drug Development Offering
 

Keywords :   


PAREXEL Expands Model-Based Drug Development Offering

2015-07-10 05:41:00| drugdiscoveryonline News Articles

PAREXEL International Corporation, a leading global biopharmaceutical services provider, recently announced expanded services and capabilities in model-based drug development (MBDD) through their Quantitative Clinical Development (QCD) group.

Tags: development drug offering expands

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11 10
23.11MusyaPop210
23.11S.H.Figuarts
23.11 Kanye West
23.11
23.111TC
23.11
23.11abe
More »